Huso DL - Search Results

1

Disruption of Id1 reveals major differences in angiogenesis between transplanted and autochthonous tumors.

Sikder H, Huso DL, Zhang H, Wang B, Ryu B, Hwang ST, Powell JD, Alani RM. Sikder H, et al. Among authors: huso dl. Cancer Cell. 2003 Oct;4(4):291-9. doi: 10.1016/s1535-6108(03)00245-9. Cancer Cell. 2003. PMID: 14585356 Free article.

2

NFAT binding and regulation of T cell activation by the cytoplasmic scaffolding Homer proteins.

Huang GN, Huso DL, Bouyain S, Tu J, McCorkell KA, May MJ, Zhu Y, Lutz M, Collins S, Dehoff M, Kang S, Whartenby K, Powell J, Leahy D, Worley PF. Huang GN, et al. Among authors: huso dl. Science. 2008 Jan 25;319(5862):476-81. doi: 10.1126/science.1151227. Science. 2008. PMID: 18218901 Free PMC article.

3

Mutant PIK3CA promotes cell growth and invasion of human cancer cells.

Samuels Y, Diaz LA Jr, Schmidt-Kittler O, Cummins JM, Delong L, Cheong I, Rago C, Huso DL, Lengauer C, Kinzler KW, Vogelstein B, Velculescu VE. Samuels Y, et al. Among authors: huso dl. Cancer Cell. 2005 Jun;7(6):561-73. doi: 10.1016/j.ccr.2005.05.014. Cancer Cell. 2005. PMID: 15950905 Free article.

4

Short telomeres, even in the presence of telomerase, limit tissue renewal capacity.

Hao LY, Armanios M, Strong MA, Karim B, Feldser DM, Huso D, Greider CW. Hao LY, et al. Cell. 2005 Dec 16;123(6):1121-31. doi: 10.1016/j.cell.2005.11.020. Cell. 2005. PMID: 16360040 Free article.

5

Targeting vascular and avascular compartments of tumors with C. novyi-NT and anti-microtubule agents.

Dang LH, Bettegowda C, Agrawal N, Cheong I, Huso D, Frost P, Loganzo F, Greenberger L, Barkoczy J, Pettit GR, Smith AB 3rd, Gurulingappa H, Khan S, Parmigiani G, Kinzler KW, Zhou S, Vogelstein B. Dang LH, et al. Cancer Biol Ther. 2004 Mar;3(3):326-37. doi: 10.4161/cbt.3.3.704. Epub 2004 Mar 12. Cancer Biol Ther. 2004. PMID: 14739784 Free article.

6

Specific ablation of Stat3beta distorts the pattern of Stat3-responsive gene expression and impairs recovery from endotoxic shock.

Yoo JY, Huso DL, Nathans D, Desiderio S. Yoo JY, et al. Among authors: huso dl. Cell. 2002 Feb 8;108(3):331-44. doi: 10.1016/s0092-8674(02)00636-0. Cell. 2002. PMID: 11853668 Free article.

7

The Notch pathway inhibits TGFβ signaling in breast cancer through HEYL-mediated crosstalk.

Han L, Diehl A, Nguyen NK, Korangath P, Teo W, Cho S, Kominsky S, Huso DL, Feigenbaum L, Rein A, Argani P, Landberg G, Gessler M, Sukumar S. Han L, et al. Among authors: huso dl. Cancer Res. 2014 Nov 15;74(22):6509-18. doi: 10.1158/0008-5472.CAN-14-0816. Epub 2014 Sep 12. Cancer Res. 2014. PMID: 25217524 Free PMC article.

8

Telomere fusion to chromosome breaks reduces oncogenic translocations and tumour formation.

Qi L, Strong MA, Karim BO, Huso DL, Greider CW. Qi L, et al. Among authors: huso dl. Nat Cell Biol. 2005 Jul;7(7):706-11. doi: 10.1038/ncb1276. Epub 2005 Jun 19. Nat Cell Biol. 2005. PMID: 15965466 Free article.

9

The HMG-I oncogene causes highly penetrant, aggressive lymphoid malignancy in transgenic mice and is overexpressed in human leukemia.

Xu Y, Sumter TF, Bhattacharya R, Tesfaye A, Fuchs EJ, Wood LJ, Huso DL, Resar LM. Xu Y, et al. Among authors: huso dl. Cancer Res. 2004 May 15;64(10):3371-5. doi: 10.1158/0008-5472.CAN-04-0044. Cancer Res. 2004. PMID: 15150086

10

The high-mobility group A1 gene up-regulates cyclooxygenase 2 expression in uterine tumorigenesis.

Tesfaye A, Di Cello F, Hillion J, Ronnett BM, Elbahloul O, Ashfaq R, Dhara S, Prochownik E, Tworkoski K, Reeves R, Roden R, Ellenson LH, Huso DL, Resar LM. Tesfaye A, et al. Among authors: huso dl. Cancer Res. 2007 May 1;67(9):3998-4004. doi: 10.1158/0008-5472.CAN-05-1684. Cancer Res. 2007. PMID: 17483309

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

153 results

Search Page

Filters